Trial Type: Gastric Cancer

LS-P-HAT
A Phase 1 Study of NM32-2668 (Anti ROR1/Anti CD3/Anti-HSA Tri-Specific Antibody) in Adult Patients with Selected Advanced Solid Tumors
Status: Open
Trial Type: Breast Cancer, Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer, Melanoma and Skin Cancers, Ovarian Cancer, Soft Tissue and Bone Cancer, Uterine Cancer
Contact: Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org
LS-P-DisTinGuish
DKN-01, Tislelizumab ± Chemotherapy as First-Line or Second-Line Therapy for metastatic gastric and esophageal cancer
Status: Open
Trial Type: Gastric Cancer
Contact: Dr. Khaldoun Almhanna
kalmhanna@lifespan.org
LS-P-TIDE
inhibitor of MTAP for patients with MTAP gene alterations in gastric esophageal, NSCLC and bladder cancer
Status: Open
Trial Type: Early Phase Trials for Multiple Cancer Types, Esophageal Cancer, Gastric Cancer, Kidney and Bladder Cancer, Lung Cancer
Contact: Dr. Benedito Carneiro
Benedito.carneiro@lifespan.org

©2024 Brown Cancer Clinical Trials